|
|
|
|
| LEADER |
00000cam a2200000Ia 4500 |
| 001 |
EBSCO_ocn697809276 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
110121s2010 nyua ob 001 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d OCLCQ
|d YDXCP
|d OCLCF
|d OCLCQ
|d TOA
|d AGLDB
|d ICA
|d D6H
|d OCLCQ
|d VTS
|d REC
|d AU@
|d STF
|d OCLCO
|d M8D
|d OCLCQ
|d K6U
|d OCLCA
|d OCLCO
|d OCL
|d OCLCQ
|d OCLCO
|
| 020 |
|
|
|a 9781612092195
|q (electronic bk.)
|
| 020 |
|
|
|a 1612092195
|q (electronic bk.)
|
| 020 |
|
|
|z 9781608760152
|
| 020 |
|
|
|z 1608760154
|
| 029 |
1 |
|
|a DEBBG
|b BV043961024
|
| 029 |
1 |
|
|a DEBSZ
|b 481296220
|
| 029 |
1 |
|
|a AU@
|b 000056816096
|
| 035 |
|
|
|a (OCoLC)697809276
|
| 050 |
|
4 |
|a R850
|b .A38eb vol.3
|
| 072 |
|
7 |
|a MED
|x 108000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 610.28/4
|2 22
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Advances in medicine and biology.
|n Vol. 3 /
|c Leon V. Berhardt, editor.
|
| 260 |
|
|
|a New York :
|b Nova Science Publishers,
|c ©2010.
|
| 300 |
|
|
|a 1 online resource (xii, 277 pages) :
|b illustrations (some color)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Advances in biology and medicine series
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a ADVANCES IN MEDICINE AND BIOLOGY, VOLUME 3 ; ADVANCES IN MEDICINE AND BIOLOGY, VOLUME 3 ; CONTENTS ; PREFACE ; THE EFFECTS OF DRUGS ON VERBAL FLUENCY: MECHANISMS OF DRUG RELATED FLUENCY IN APHASIA; ABSTRACT ; INTRODUCTION ; NEUROANATOMY OF SPEECH AND LANGUAGE ; NEUROCHEMICAL BASES OF SPEECH AND LANGUAGE ; The Primary Neurotransmitters ; DEFINITION OF FLUENCY ; NEUROPHARMACOLOGY OF VERBAL FLUENCY, SPEECH AND LANGUAGE ; CLINICAL CASE ; CONCLUSION ; REFERENCES ; ANTI-TUMORAL EFFECTS OF PULSED LOW ELECTRIC FIELD ENHANCED CHEMOTHERAPY: LESSONS FROM EXPERIMENTAL MALIGNANT TUMORS ; ABSTRACT.
|
| 505 |
8 |
|
|a 1. INTRODUCTION 1.1. Enhancement of the Uptake of Molecules and Macromolecules by Cells ; 1.2. Enhanced Uptake of Molecules and Macromolecules by Non-Permeabilizing Unipolar Pulsed Low Electric Fields (LEF) ; 1.3. The Difference between Enhanced Uptake of Molecules Induced by Electroporation and by Unipolar Pulsed Train of Low Electric Fields (LEF) ; 1.4. Application of Electric Based Cancer Therapy ; 1.4.1. Electrotherapy by low intensity DC electric-fields (LIEF) ; 1.4.2. Electrochemotherapy by high electric fields (ECT) ; 1.4.3. Electrotherapy by high frequency electric fields.
|
| 505 |
8 |
|
|a 1.4.4. Electro-hyperthermia 2. ANTI-TUMORAL EFFECTS OF LOW ELECTRIC FIELD CANCER TREATMENT-ENHANCED CHEMOTHERAPY (LEFCT-EC) ; 2.1. Experimental Design and Methods ; 2.1.1. Experimental metastatic tumors. ; 2.1.2. Chemotherapy ; 2.1.3. Low electric field cancer therapy protocol ; 2.2. Treatment of Mouse Melanoma Derived Tumors by LEFCT-EC ; 2.3. Treatment of Mouse Mammary Carcinoma Derived Tumors by LEFCT-EC ; 2.4. Effective Treatment of Mouse Metastatic Squamous Cell Carcinoma (SCC) Cancer by Low Electric Fields and Chemotherapy.
|
| 505 |
8 |
|
|a 2.5. Effective Treatment of Mouse Metastatic Prostate Cancer by Low Electric Fields and Chemotherapy 2.6. Cure of Primary Colon Cancer Derived Tumors and Reduction in the Metastatic Load Following LEFCT-EC ; 2.6.1. The role of the electric pulse intensity ; 2.6.2. The combination of the electric stimulus with different chemotherapeutic drugs ; 2.6.3. The ability of LEFCT-EC to control primary as well as metastatic disease ; 3. THE INVOLVEMENT OF IMMUNOLOGICAL COMPONENTS IN THE ARREST OF METASTATIC GROWTH ACHIEVED BY DESTRUCTION OF THE PRIMARY TUMOR BY LEFCT AND LEFCT-EC.
|
| 505 |
8 |
|
|a 3.1. The Development of an Anti Tumoral Reaction Following LEFCT-EC of B16 Melanoma 3.2. Breast Cancer Cell (DA3) Tumor Destruction by LEFCT and LEFCT-EC Triggered Anti Tumor Reaction ; 3.3. SCC Tumor (SQ2) Destruction by LEFCT And LEFCT-EC and Anti Tumor Reaction ; 3.4. Anti Tumor Immunity against Prostate Cancer Cell Tumors (TRAMP) Following Destruction of the Tumors by LEFCT-EC ; 3.5. Involvement of the Immune Response in the Cure of Metastatic Murine CT-26 Colon Carcinoma by LEFCT-EC ; 3.6. Induction of Anti-Tumor Immunity by Other Ablation Mechanisms, Which Cause in Situ Tumor Ablation.
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Medicine.
|
| 650 |
|
0 |
|a Biology.
|
| 650 |
|
0 |
|a Clinical medicine.
|
| 650 |
1 |
2 |
|a Clinical Medicine
|
| 650 |
2 |
2 |
|a Biomedical Research
|
| 650 |
|
2 |
|a Medicine
|
| 650 |
|
2 |
|a Biology
|
| 650 |
|
6 |
|a Médecine.
|
| 650 |
|
6 |
|a Biologie.
|
| 650 |
|
6 |
|a Médecine clinique.
|
| 650 |
|
7 |
|a medicines (material)
|2 aat
|
| 650 |
|
7 |
|a biology.
|2 aat
|
| 650 |
|
7 |
|a medicine (discipline)
|2 aat
|
| 650 |
|
7 |
|a MEDICAL
|x Instruments & Supplies.
|2 bisacsh
|
| 650 |
|
7 |
|a Clinical medicine
|2 fast
|
| 650 |
|
7 |
|a Biology
|2 fast
|
| 650 |
|
7 |
|a Medicine
|2 fast
|
| 700 |
1 |
|
|a Berhardt, Leon V.
|
| 776 |
0 |
8 |
|i Print version:
|t Advances in medicine and biology. Vol. 3.
|d New York. : Nova Science Publishers, ©2010
|z 9781608760152
|w (DLC) 2009049829
|w (OCoLC)470694959
|
| 830 |
|
0 |
|a Advances in biology and medicine series.
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=343898
|z Texto completo
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 343898
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 3602699
|
| 994 |
|
|
|a 92
|b IZTAP
|
